Home/Orexo/Robert Rönn
RR

Robert Rönn

SVP & Head of R&D

Orexo

Orexo Pipeline

DrugIndicationPhase
OX640Anaphylaxis rescuePhase 2/3
IzipryOpioid overdose rescueFDA Review (CRL)
AmorphOX-SemaglutideMetabolic Disease (e.g., Obesity, Diabetes)Pre-clinical
AmorphOX-Vaccine (w/ Abera)Prophylactic VaccinationPre-clinical